Syngeneic murine glioblastoma models: reactionary immune changes and immunotherapy intervention outcomes.
Sign Up to like & getrecommendations! Published in 2022 at "Neurosurgical focus"
DOI: 10.3171/2021.11.focus21556
Abstract: Glioblastoma is the most common primary malignant brain neoplasm with dismal 10-year survival rates of < 1%. Despite promising preliminary results from several novel therapeutic agents, clinical responses have been modest due to several factors,… read more here.
Keywords: glioblastoma models; syngeneic murine; models reactionary; murine glioblastoma ... See more keywords